文献速递运动医学关节外科

经胫骨与经前内侧股骨隧道定位在前交叉韧带重建术后影像学创伤性骨关节炎发生率的系统综述与荟萃分析

Higher Incidence of Radiographic Posttraumatic Osteoarthritis With Transtibial Femoral Tunnel Positioning Compared With Anteromedial Femoral Tunnel Positioning During Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis.
PubMed 文献 · Am J Sports Med · 2021-03-26

该系统综述与荟萃分析纳入16项研究共1546例患者,比较经胫骨(TT)与前内侧(AM)股骨隧道定位在前交叉韧带重建(ACLR)后影像学创伤性骨关节炎(PTOA)的发生率。结果显示TT组PTOA总体发生率显著高于AM组(49.3% vs 25.4%,P < .001),按5-10年和>10年随访分层后差异仍显著。

要点

  • TT组影像学PTOA总体发生率显著高于AM组(49.3% vs 25.4%,P < .001)。
  • 5-10年随访分层:TT组53.7% vs AM组14.2%(P < .001)。
  • >10年随访分层:TT组45.6% vs AM组31.2%(P < .0001)。

核心结论

  • TT ACLR与AM ACLR相比,影像学PTOA总体发生率更高。
  • 按随访时间分层(5-10年和>10年),TT组影像学PTOA发生率仍显著高于AM组。

研究设计与样本

  • 系统综述与荟萃分析,检索Cochrane Database of Systematic Reviews、Cochrane Central Register of Controlled Trials、PubMed(1980-2019)和MEDLINE(1980-2019)。
  • 纳入16项研究,共1546例患者,平均随访10.9年(范围5.4-17.8年)。
  • 采用DerSimonian-Laird随机效应模型比较TT与AM入路ACLR后PTOA的加权比例。

主要发现

  • 783例(50.6%)患者接受TT ACLR,其中401例(加权均值49.3%)发生影像学PTOA。
  • 763例(49.4%)患者接受AM ACLR,其中166例(均值21.8%)发生影像学PTOA。
  • 荟萃分析显示TT组PTOA发生率显著高于AM组(49.3% vs 25.4%,P < .001)。
  • 5-10年随访分层:TT组53.7% vs AM组14.2%(P < .001)。
  • >10年随访分层:TT组45.6% vs AM组31.2%(P < .0001)。

关键数值与推荐

  • AM组平均随访10.8年(范围5.4-17年),TT组平均随访11.4年(范围6-17.8年)。
  • TT ACLR后影像学PTOA总体发生率为49.3%,AM ACLR后为25.4%(P < .001)。

临床怎么用

  • 在ACLR中,AM股骨隧道定位可能与较低的影像学PTOA发生率相关,TT定位者需关注长期骨关节炎风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anteromedial (AM) femoral tunnel positioning in anterior cruciate ligament reconstruction (ACLR) has been reported by some authors to yield superior clinical and functional outcomes compared with the transtibial (TT) approach; however, differences in the subsequent rates of posttraumatic osteoarthritis (PTOA) are not clear. PURPOSE: To perform a systematic review and meta-analysis of the literature to evaluate the influence of femoral tunnel positioning during primary ACLR on the development of radiographic PTOA. STUDY DESIGN: Systematic review and Meta-analysis. METHODS: The Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials, PubMed (1980-2019), and MEDLINE (1980-2019) were queried for all studies describing the development of PTOA after TT or AM ACLR. Data pertaining to patient demographics, ACLR technique, and radiographic PTOA were extracted. A meta-analysis utilizing the DerSimonian-Laird method for random effects was used to compare the weighted proportion of PTOA after ACLR between the TT and AM approaches. RESULTS: There were 16 studies identified for inclusion with a total of 1546 patients. The mean follow-up across all studies was 10.9 years (range, 5.4-17.8 years). The mean follow-up in the AM and TT groups was 10.8 years (range, 5.4-17 years) and 11.4 years (range, 6-17.8 years), respectively. A total of 783 (50.6%) patients underwent TT ACLR. Of these patients, 401 (weighted mean, 49.3%) developed radiographic PTOA. A total of 763 (49.4%) patients underwent AM ACLR. Of these patients, 166 (mean, 21.8%) went on to develop radiographic PTOA. The meta-analysis demonstrated a significantly greater rate of PTOA after ACLR using a TT technique compared with an AM technique overall (49.3% vs 25.4%, respectively; P < .001) and when studies were stratified by 5- to 10-year (53.7% vs 14.2%, respectively; P < .001) and greater than 10-year (45.6% vs 31.2%, respectively; P < .0001) follow-up. CONCLUSION: TT ACLR was associated with higher overall rates of radiographic PTOA compared with the AM ACLR approach. The rates of radiographic PTOA after ACLR with a TT approach were also significantly higher than using an AM approach when stratified by length of follow-up (5- to 10-year and >10-year follow-up).

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Cinque ME, Kunze KN, Williams BT, et al. Higher Incidence of Radiographic Posttraumatic Osteoarthritis With Transtibial Femoral Tunnel Positioning Compared With Anteromedial Femoral Tunnel Positioning During Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis. Am J Sports Med. 2021. PMID: 33769902. doi:10.1177/0363546521993818

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。